Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on November 5. Just a day after the American election, Juan believes crypto could start a massive run up …

And one special coin could do even better.

RVLP Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Notice: This stock is marked as potentially delisted. It may not be actively trading.

Insider Ownership Percentage: 4.40%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $348,059.19

RVL Pharmaceuticals Insider Trading History Chart

RVL Pharmaceuticals Share Price & Price History

^$0.00

+0.30 (1.20%)

As of 10/21/2023 12:59 AM ET

320 hedge funds just sold this stock

From Chaikin Analytics | Ad

320 hedge funds just sold this stock A strange force has seized control of Wall Street. Hedge funds are already moving their money… and preparing for even stranger days ahead. Over 320 hedge funds have quietly sold THIS famous stock – to prepare for a dramatic market shift

Get the strange truth from a 50-year Wall Street insider… including the name and ticker of the stock

RVL Pharmaceuticals Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
10/20/2023	Ltd Altchem	Major Shareholder	Sell	4,758,899	$0.03	$142,766.97	4,941,101
10/18/2023	Foundation Harsaul	Major Shareholder	Sell	3,421,537	$0.06	$205,292.22	19,063,760

Election warning coming true…

From Porter & Company | Ad

If you missed it, my emergency election broadcast is now available - watch it before it's too late.

Click here to watch it now.

SEC Filings (Institutional Ownership Changes) for RVL Pharmaceuticals (NASDAQ:RVLP)

14.36% of RVL Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

RVL Pharmaceuticals Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
8/14/2023	ArrowMark Colorado Holdings LLC	1,506,002	$0.84M	0.0%	-7.2%	1.516%
5/15/2023	AIGH Capital Management LLC	1,256,393	$1.43M	0.5%	-30.3%	1.265%
5/12/2023	Scoggin Management LP	500,000	$0.57M	0.3%	N/A	0.503%
5/3/2023	Insight Advisors LLC PA	75,646	$86K	0.0%	+100.0%	0.076%
2/16/2023	AIGH Capital Management LLC	1,801,864	$2.02M	0.7%	+143.6%	1.815%
11/15/2022	Titleist Asset Management LTD.	98,151	$0.21M	0.0%	-17.0%	0.099%
11/14/2022	Worth Venture Partners LLC	185,647	$0.39M	0.2%	N/A	0.187%
11/14/2022	UBS Oconnor LLC	276,428	$0.58M	0.0%	N/A	0.279%
11/14/2022	IPG Investment Advisors LLC	17,500	$37K	0.0%	N/A	0.018%
11/7/2022	Virtu Financial LLC	22,835	$48K	0.0%	N/A	0.023%
10/25/2022	Raymond James Financial Services Advisors Inc.	29,519	$62K	0.0%	N/A	0.030%
8/11/2022	Insight Advisors LLC PA	37,823	$59K	0.0%	N/A	0.045%
8/8/2022	Marietta Wealth Management LLC	120,000	$0.16M	0.0%	N/A	0.144%

Data available starting January 2016

RVL Pharmaceuticals plc, a specialty pharmaceutical company, focuses on the development and commercialization of pharmaceutical products that target markets with underserved patient populations in the ocular and medical aesthetics therapeutic areas in the United States, Argentina, and Hungary. It is commercializing Upneeq (RVL-1201), an oxymetazoline hydrochloride ophthalmic solution, for the treatment of acquired blepharoptosis, or low-lying eyelid in adults. The company was formerly known as Osmotica Pharmaceuticals plc and changed its name to RVL Pharmaceuticals plc in January 2022. RVL Pharmaceuticals plc is headquartered in Bridgewater, New Jersey.

Today's Range

Now: N/A

50 Day Range

MA: $0.04

$0.00

$0.19

52 Week Range

Now: N/A

Volume

63,964,300 shs

Average Volume

N/A

Market Capitalization

N/A

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of RVL Pharmaceuticals?: RVL Pharmaceuticals' top insider investors include:
Foundation Harsaul (Major Shareholder)
Ltd Altchem (Major Shareholder)
Learn More about top insider investors at RVL Pharmaceuticals.

Crypto’s next big bull run?

From Weiss Ratings | Ad